{"id":"https://openalex.org/W1971834278","doi":"https://doi.org/10.3109/13506120308995249","title":"Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of A\u03b242in patients with Alzheimer's disease","display_name":"Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of A\u03b242in patients with Alzheimer's disease","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W1971834278","doi":"https://doi.org/10.3109/13506120308995249","mag":"1971834278","pmid":"https://pubmed.ncbi.nlm.nih.gov/12762134"},"language":"en","primary_location":{"id":"doi:10.3109/13506120308995249","doi":"https://doi.org/10.3109/13506120308995249","is_oa":false,"landing_page_url":"https://doi.org/10.3109/13506120308995249","pdf_url":null,"source":{"id":"https://openalex.org/S25535963","display_name":"Amyloid","issn_l":"1350-6129","issn":["1350-6129","1744-2818"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1971834278"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110956934","display_name":"Christoph H\u00f6ck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christoph Hock","raw_affiliation_strings":["Division of Psychiatry Research, University of Z\u00fcrich, Lenggstrasse 31, CH-8029 Z\u00fcrich, Switzerland. chock@bli.unizh.ch","Division of Psychiatry Research, University of Z\u00fcrich, Lenggstrasse 31, CH-8029 Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry Research, University of Z\u00fcrich, Lenggstrasse 31, CH-8029 Z\u00fcrich, Switzerland. chock@bli.unizh.ch","institution_ids":["https://openalex.org/I202697423"]},{"raw_affiliation_string":"Division of Psychiatry Research, University of Z\u00fcrich, Lenggstrasse 31, CH-8029 Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111970555","display_name":"Alessia S. Maddalena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alessia Maddalena","raw_affiliation_strings":["Division of Psychiatry Research, University of Zurich, Switzerland","[University of Zurich, Z\u00fcrich, Switzerland]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry Research, University of Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]},{"raw_affiliation_string":"[University of Zurich, Z\u00fcrich, Switzerland]","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046877786","display_name":"Andreas Raschig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andreas Raschig","raw_affiliation_strings":["Boehringer Ingelheim Pharma KG, Biberach, Germany","Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany;","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110084335","display_name":"Franz M\u00fcller-Spahn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Franz M\u00fcller-Spahn","raw_affiliation_strings":["Department of Psychiatry, University of Basel, Switzerland","Universit\u00e4t Basel Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]},{"raw_affiliation_string":"Universit\u00e4t Basel Basel, Switzerland","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007009029","display_name":"Gerhard Wilhelm Eschweiler","orcid":"https://orcid.org/0009-0007-2630-5928","observed_orcids":["https://orcid.org/0009-0007-2630-5928"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerhard Eschweiler","raw_affiliation_strings":["Department of Psychiatry, University of Tubingen, Germany","Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Tubingen, Germany","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Germany#TAB#","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100787761","display_name":"Klaus Huger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus Huger","raw_affiliation_strings":["Clinic for Medical Rehabilitation and Geriatrics (Henrietten-Foundation), Hannover, Germany","Clinic for Medical Rehabilitation and Geriatrics, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic for Medical Rehabilitation and Geriatrics (Henrietten-Foundation), Hannover, Germany","institution_ids":[]},{"raw_affiliation_string":"Clinic for Medical Rehabilitation and Geriatrics, Hannover, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109324069","display_name":"I Hewer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isabella Hewer","raw_affiliation_strings":["Department of Psychiatry, Free University of Berlin, Germany","Freie Universit\u00e4t Berlin  Berlin Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Free University of Berlin, Germany","institution_ids":["https://openalex.org/I75951250"]},{"raw_affiliation_string":"Freie Universit\u00e4t Berlin  Berlin Germany","institution_ids":["https://openalex.org/I75951250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037109052","display_name":"Harald Juergen Hampel","orcid":"https://orcid.org/0000-0003-0894-8982","observed_orcids":["https://orcid.org/0000-0003-0894-8982"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harald Hampel","raw_affiliation_strings":["Department of Psychiatry, University of Munich, Germany","Ludwig\u2010Maximilians\u2010Universit\u00e4t M\u00fcnchen Munich Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Munich, Germany","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"Ludwig\u2010Maximilians\u2010Universit\u00e4t M\u00fcnchen Munich Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100787762","display_name":"Thomas M\u00fcller-Thornsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159176309","display_name":"Universit\u00e4t Hamburg","ror":"https://ror.org/00g30e956","country_code":"DE","type":"education","lineage":["https://openalex.org/I159176309"]},{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas M\u00fcller-Thornsen","raw_affiliation_strings":["Department of Psychiatry, University of Hamburg, Germany","Universit\u00e4tsklinikum Hamburg-Eppendorf und Medizinische Fakult\u00e4t, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Hamburg, Germany","institution_ids":["https://openalex.org/I159176309"]},{"raw_affiliation_string":"Universit\u00e4tsklinikum Hamburg-Eppendorf und Medizinische Fakult\u00e4t, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114257708","display_name":"Wolfgang H. Oertel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wolfgang Oertel","raw_affiliation_strings":["Department of Neurology, University of Marburg, Germany","Philipps\u2010Universit\u00e4t Marburg, Marburg Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Marburg, Germany","institution_ids":["https://openalex.org/I161103922"]},{"raw_affiliation_string":"Philipps\u2010Universit\u00e4t Marburg, Marburg Germany","institution_ids":["https://openalex.org/I161103922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012230896","display_name":"M. Wienrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marion Wienrich","raw_affiliation_strings":["Boehringer Ingelheim GmbH Ingelheim, Germany","Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim GmbH Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany;","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082070724","display_name":"Andri Signorell","orcid":"https://orcid.org/0000-0003-4311-1969","observed_orcids":["https://orcid.org/0000-0003-4311-1969"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andri Signorell","raw_affiliation_strings":["Division of Psychiatry Research, University of Zurich, Switzerland","[University of Zurich, Z\u00fcrich, Switzerland]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry Research, University of Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]},{"raw_affiliation_string":"[University of Zurich, Z\u00fcrich, Switzerland]","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061795301","display_name":"Charo Gonzalez-Agosti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charo Gonzalez-agosti","raw_affiliation_strings":["Division of Psychiatry Research, University of Zurich, Switzerland","[University of Zurich, Z\u00fcrich, Switzerland]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry Research, University of Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]},{"raw_affiliation_string":"[University of Zurich, Z\u00fcrich, Switzerland]","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109156775","display_name":"Roger M. Nitsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger M. Nitsch","raw_affiliation_strings":["Division of Psychiatry Research, University of Zurich, Switzerland","[University of Zurich, Z\u00fcrich, Switzerland]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry Research, University of Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]},{"raw_affiliation_string":"[University of Zurich, Z\u00fcrich, Switzerland]","institution_ids":["https://openalex.org/I202697423"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5110956934"],"corresponding_institution_ids":["https://openalex.org/I202697423"],"apc_list":null,"apc_paid":null,"fwci":2.304,"has_fulltext":false,"cited_by_count":119,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8825589,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"1","last_page":"6"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/muscarinic-m1-receptor-agonist","display_name":"muscarinic M1 receptor agonist","score":0.9049999713897705},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9679999947547913},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":0.8859999775886536},{"id":"https://openalex.org/keywords/amyloid-beta-40","display_name":"A\u03b240","score":0.9819999933242798},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-biomarkers","display_name":"cerebrospinal fluid biomarkers","score":0.9240000247955322},{"id":"https://openalex.org/keywords/alpha-secretase","display_name":"alpha-secretase","score":0.734000027179718},{"id":"https://openalex.org/keywords/app-processing","display_name":"APP processing","score":0.8230000138282776},{"id":"https://openalex.org/keywords/non-amyloidogenic-pathway","display_name":"non-amyloidogenic pathway","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.7251471281051636},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.6364120244979858},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6300356388092041},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6124131083488464},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5694846510887146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5242988467216492},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5066905617713928},{"id":"https://openalex.org/C2776156579","wikidata":"https://www.wikidata.org/wiki/Q417667","display_name":"Amyloid beta","level":3,"score":0.43990030884742737},{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.4297291934490204},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.42718666791915894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35588401556015015},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3358612060546875},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2651670575141907},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.257706880569458},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20711290836334229},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D018721","descriptor_name":"Muscarinic Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D043643","descriptor_name":"Receptor, Muscarinic M1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3109/13506120308995249","doi":"https://doi.org/10.3109/13506120308995249","is_oa":false,"landing_page_url":"https://doi.org/10.3109/13506120308995249","pdf_url":null,"source":{"id":"https://openalex.org/S25535963","display_name":"Amyloid","issn_l":"1350-6129","issn":["1350-6129","1744-2818"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid","raw_type":"journal-article"},{"id":"pmid:12762134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12762134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis","raw_type":"Clinical Trial"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/62228","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/62228","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hock, C., Maddalena, A., Raschig, A., M\u00fcller-Spahn, F., Eschweiler, G., Hager, K., Heuser, I., Hampel, H., M\u00fcller-Thomsen, T., Oertel, W., Wienrich, M., Signorell, A., Gonzalez-Agosti, C., & Nitsch, R. M. (2003). Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer\u2019s disease. Amyloid, 10, 1\u20136. https://doi.org/10.3109/13506120308995249","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W182142939","https://openalex.org/W1510308646","https://openalex.org/W1693283493","https://openalex.org/W1825726719","https://openalex.org/W1847168837","https://openalex.org/W1967733770","https://openalex.org/W1977106083","https://openalex.org/W1978106990","https://openalex.org/W1979240613","https://openalex.org/W1982206682","https://openalex.org/W1988923764","https://openalex.org/W1990543766","https://openalex.org/W2002376137","https://openalex.org/W2009389965","https://openalex.org/W2026593926","https://openalex.org/W2032862146","https://openalex.org/W2033382511","https://openalex.org/W2046766517","https://openalex.org/W2058873320","https://openalex.org/W2080032078","https://openalex.org/W2091241078","https://openalex.org/W2101077392","https://openalex.org/W2105704879","https://openalex.org/W2122230892","https://openalex.org/W2156220037"],"related_works":["https://openalex.org/W2093061821","https://openalex.org/W1982341565","https://openalex.org/W1978106990","https://openalex.org/W2058873320","https://openalex.org/W2006131134","https://openalex.org/W2022469551","https://openalex.org/W2080187876","https://openalex.org/W2148750503","https://openalex.org/W1990490965"],"abstract_inverted_index":{"The":[0,92,132],"amyloid":[1,37,238],"beta-peptides":[2],"A":[3,7,70,74,117,139,176,222,227],"beta":[4,8,41,71,75,118,140,177,223,228],"40":[5,72,105,178],"and":[6,46,73,81,100,143,202,225],"42":[9,76,119,141],"are":[10],"highly":[11],"amyloidogenic":[12],"constituents":[13],"of":[14,32,69,85,88,116,123,138,175,241],"brain":[15],"beta-amyloid":[16],"plaques":[17],"in":[18,61,96,230],"Alzheimer's":[19],"disease":[20],"(AD).":[21],"Lowering":[22],"their":[23],"formation":[24],"may":[25],"be":[26],"achieved":[27],"by":[28,78,120],"modulating":[29],"the":[30,36,83,217],"activities":[31],"proteases":[33],"that":[34,56,214],"cleave":[35],"precursor":[38],"protein":[39],"(A":[40],"PP),":[42],"including":[43],"alpha-":[44],"beta-,":[45],"gamma-secretases.":[47],"Talsaclidine":[48,109],"is":[49],"a":[50,97,121,236],"functionally":[51],"selective":[52],"muscarinic":[53],"m1":[54,218],"agonist":[55,219],"stimulates":[57],"non-amyloidogenic":[58],"alpha-secretase":[59],"processing":[60],"vitro.":[62],"We":[63],"compared":[64,129,158],"cerebrospinal":[65],"fluid":[66],"(CSF)":[67],"levels":[68,115,137,174],"measured":[77],"ELISA":[79],"before":[80,142],"at":[82],"end":[84],"4":[86],"weeks":[87],"treatment":[89,145,181,192,215],"with":[90,107,146,165,182,193,216],"talsaclidine.":[91],"medication":[93],"was":[94,151],"administered":[95],"double-blind,":[98],"placebo-controlled,":[99],"randomized":[101],"clinical":[102],"study":[103],"to":[104,130,159],"patients":[106],"AD.":[108,242],"(n":[110,148,167,184,195],"=":[111,149,168,185,196],"34)":[112,150],"decreased":[113],"CSF":[114,136,173],"median":[122],"19%":[124],"(p":[125,170],"<":[126,171,209],"0.001)":[127],"as":[128,157,235],"baseline.":[131],"mean":[133],"difference":[134],"between":[135],"after":[144],"talsaclidine":[147,194,220],"-46":[152],"+/-":[153,161,199,204],"73":[154],"(SD)":[155,163],"pg/ml":[156,164],"0":[160],"8":[162],"placebo":[166,183],"6)":[169,186],"0.05).":[172,210],"increased":[179],"during":[180,191],"while":[187],"they":[188],"remained":[189],"stable":[190],"31)":[197],"(1.118":[198],"1.710":[200],"ng/ml,":[201,206],"-0.170":[203],"0.967":[205],"respectively;":[207],"p":[208],"These":[211],"data":[212],"show":[213],"reduced":[221],"peptides,":[224],"particularly":[226],"42,":[229],"AD":[231],"patients,":[232],"suggesting":[233],"it":[234],"potential":[237],"lowering":[239],"therapy":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1971834278","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
